Press Releases

DALLAS, Nov. 20, 2019 /PRNewswire/ -- Due to the risk of False Claims Act investigations and corresponding liability demands, Oberheiden, P.C. is encouraging health care providers who billed Medicare for Point-Stimulation Therapy ("P-Stim") devices in the past to proactively discuss the option of a voluntary CMS self-disclosure of past billing violations with experienced

MIAMI, Nov. 20, 2019 /PRNewswire/ -- The Diabetes Research Institute (DRI) has made significant progress toward a cure – thanks in large part to dedicated

MINNEAPOLIS, Nov. 20, 2019 /PRNewswire/ -- Today, Mednet, a provider of eClinical solutions for the global life sciences community and Assign DMB, a contract research organization (CRO) with deep expertise in data management and biostatistics, announced they extended their four-year relationship. Through the new agreement, Mednet will provide Assign DMB with concier

SEATTLE, Nov. 20, 2019 /PRNewswire/ -- Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announced that a narrative review of dihydroergotamine (DHE) was published online in Headache,

WHIPPANY, N.J., Nov. 20, 2019 /PRNewswire/ -- Bayer announced today it has joined Know Diabetes by Heart™, a joint initiative of the American Heart Association and

NAPA, Calif., Nov. 20, 2019 /PRNewswire/ -- The Doctors Company announced today the promotion of longtime company executive Marco Vanderlaan to chief financial officer (CFO) and chief risk officer.

CHICAGO, Nov. 20, 2019 /PRNewswire/ -- Virtually every health system in America has initiated efforts to "do" digital things, but only a few have consciously defined what it means for them to "be" digital in the future delivery landscape. Today, The Chartis Group, a healthcare advisory firm, released a paper,

CAMBRIDGE, England and BOSTON, Nov. 20, 2019 /PRNewswire/ -- IOTA Pharmaceuticals Ltd (Cambridge, UK) and the Experimental Therapeutic Unit of the Neurology Department of Massachusetts General Hospital (Neurology, MGH, Boston, USA) today announced the creation of a new

SYDNEY, Nov. 20, 2019 /PRNewswire/ -- One of the world's most renowned Chemists and co-founder of the biopharmaceutical company, Pharmacyclics, Professor Jonathan L. Sessler has been appointed as a Non-Executive Director to the board of OncoTEX Inc., it was announced today.OncoTEX Inc. is a member company of The iQ Group Global

HYDERABAD, India, Nov. 20, 2019 /PRNewswire/ -- Excelra, a leading global Data and Analytics Company today announced a Drug Repurposing collaboration with Osaka-based Maruho – a pharmaceutical company specialising in Dermatology.